BBP (Virtus Biotech ETF) Stock Analysis - Politician Trades

Virtus Biotech ETF (BBP) is a publicly traded the market company. As of May 21, 2026, BBP trades at $90.21 with a market cap of $0 and a P/E ratio of 0.00. BBP moved +3.43% today. Year to date, BBP is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces BBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded BBP stock?

Rallies tracks politician and congressional stock disclosures for BBP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

BBP Key Metrics

Key financial metrics for BBP
MetricValue
Price$90.21
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume140.02K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BBP News

BBP Analyst Consensus

BBP analyst coverage data. Average price target: $0.00.

Common questions about BBP

Which politicians traded BBP stock?
Rallies tracks politician and congressional stock disclosures for BBP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in BBP?
Yes. Rallies tracks politician and congressional stock disclosures for BBP, including reported purchases, sales, dates, owners, and trade amounts when available.
Is BBP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BBP. It does not provide personalized investment advice.
BBP

BBP